Ray Sangeeta

Title: Ray Sangeeta: Innovator in PSMA-Targeting Compounds

Introduction

Ray Sangeeta is an accomplished inventor based in Ellicott City, MD (US). He has made significant contributions to the field of cancer imaging and therapy through his innovative work on prostate-specific membrane antigen (PSMA) targeting compounds. With a total of 2 patents, Sangeeta is recognized for his advancements in medical technology.

Latest Patents

Sangeeta's latest patents include "PSMA-targeting compounds and uses thereof" and "Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents." The first patent describes PSMA-targeting compounds and their applications for imaging, therapy, cell sorting, and tumor mapping. The second patent highlights the potential of PSMA as a target for cancer imaging and therapy, detailing the preparation of various 99mTc/Re-labeled compounds and their specific binding to engineered PSMA+ PC3 PIP tumors.

Career Highlights

Ray Sangeeta is affiliated with The Johns Hopkins University, where he continues to push the boundaries of research in cancer treatment. His work has garnered attention for its innovative approach to utilizing PSMA in medical applications.

Collaborations

Sangeeta has collaborated with notable professionals in his field, including Martin Gilbert Pomper and Ronnie Charles Mease. Their combined expertise has contributed to the advancement of research in PSMA-targeting technologies.

Conclusion

Ray Sangeeta's contributions to the field of cancer imaging and therapy through his PSMA-targeting compounds are noteworthy. His innovative patents and collaborations reflect his commitment to improving medical technology and patient outcomes.